<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-15</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-15</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>21</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>1</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
NELFè›‹ç™½åœ¨ç™Œç—‡ç»†èƒä¸­ï¼Œé€šè¿‡é˜»æ­¢è½¬å½•è¯»è¿‡åˆ°DNAå¤åˆ¶åŒºï¼Œé˜²æ­¢åŸºå› ç»„ä¸ç¨³å®šï¼Œæ˜¯ç»´æŒç™Œç—‡ç»†èƒç¨³æ€çš„å…³é”®æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚ºç»„ç»‡åŠŸèƒ½åŒºéš”ç ”ç©¶ï¼ˆOPæ‚£è€…ï¼‰<br />
- è‚è„å…ç–«ç»†èƒå“åº”è‚ç‚æ¨¡å‹<br />
- è‚ é“èŒç¾¤å¯¹éœä¹±ç”Ÿç‰©è†œå½¢æˆçš„å½±å“<br />
- éé˜»å¡æ€§æ— ç²¾å­ç—‡ä¸­lncRNAåœ¨ç²¾åŸç»†èƒå‘è‚²ä¸­çš„è°ƒæ§<br />
- ç™½è¡€ç—…ä¸­PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿çš„åŠŸèƒ½ä¸æœºåˆ¶<br />
- è§†ç½‘è†œå¢æ®–æ€§ç—…å˜ä¸­æˆçº¤ç»´ç»†èƒå¼‚è´¨æ€§<br />
- å“®å–˜æ‚£è€…ç”Ÿç‰©åˆ¶å‰‚æ²»ç–—çš„è½¬å½•ç»„å­¦å·®å¼‚<br />
- ç™Œç»†èƒé€šè¿‡å¾®å°RNAè½¬ç§»ä¾µè¢­æ€§<br />
- ç»“è‚ ç™Œç»†èƒå¯¹CTX-439çš„ååº”</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºç»„ç»‡åŠŸèƒ½éš”å®¤ã€‚<br />
- å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼ˆChIP-Seq, RNA-seq, ATAC-seq, TT-seq, POINT-seq, FLAM-Seq, RIP-Seqï¼‰è”åˆç ”ç©¶NELFåŠŸèƒ½ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (21æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE250385 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºOPæ‚£è€…è‚ºç»„ç»‡çš„åŠŸèƒ½åŒºå®¤åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ying Tang ; Cuilin Chu ; Siyuan Bu ; Qin Sun ; Airan Liu ; Lingyan Huang ; Hongmei WangSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensTo characterize the spatial characteristics of the lung tissue of OP patient, we collected lung samples for Visium CytAssist from one patient with OP<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250385" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>GSE288402 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [ChIP-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ChIP-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nakayama Chihiro ; Daigaku Yasukazu ; Aoi Yuki ; Fang Qi ; Kimura Hiroshi ; Shilatifard Ali ; Tellier Michael ; Nojima TakayukiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288402" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>GSE253012 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chihiro Nakayama ; Yasukazu Daigaku ; Yuki Aoi ; Qi Fang ; Hiroshi Kimura ; Ali Shilatifard ; Michael Tellier ; Takayuki NojimaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253012" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>GSE253011 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chihiro Nakayama ; Yasukazu Daigaku ; Yuki Aoi ; Qi Fang ; Hiroshi Kimura ; Ali Shilatifard ; Michael Tellier ; Takayuki NojimaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensRegulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that gene expression of NELFCD, a known negative elongation factor, is up-regulated in colorectal tumours. To dissect the direct role of NELF-C on Pol II transcription in such cancer, we employed an auxin-dependent protein degradation system for NELF-C in combination with nascent transcript sequencing technologies. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognised role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253011" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE313240 æ˜¯æ¥è‡ª Alb-WT Bicd2fl/fl å’Œ Alb-Cre Bicd2fl/fl å°é¼ ï¼ˆç» S-100 è¯±å¯¼çš„è‡ªèº«å…ç–«æ€§è‚ç‚æ¨¡å‹ï¼‰è‚è„å…ç–«ç»†èƒçš„å•ç»†èƒ RNA æµ‹åºæ•°æ®ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wenyu Tian ; Weixuan Wang ; Dan LvSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo determine the changes in liver immune cells upon hepatic Bicd2 deficiency, we performed scRNA-seq to analyze the hepatic immune microenvironment in Alb-WT Bicd2fl/fl and Alb-Cre Bicd2fl/fl mice subjected to S-100 induced AIH model.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313240" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE313194 æŸ æª¬é…¸è‚ è¡£èŒåŠå…¶ç›¸å…³è‚ é“å¾®ç”Ÿç‰©ç¾¤ç‰©ç§é€šè¿‡äº§ç”Ÿç”Ÿç‰©æ´»æ€§å°åˆ†å­æ¥è°ƒèŠ‚éœä¹±å¼§èŒç”Ÿç‰©è†œçš„å½¢æˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Antunes L CaetanoSeries Type : Expression profiling by high throughput sequencingOrganism : Vibrio cholerae C6706Cholera is a deadly diarrheal disease that affects millions of people globally. Although V. cholerae, the causative agent of the disease, has been extensively studied in isolation, it was relatively recently that scientists started investigating its interactions with the gut microbiota. Our group and others previously showed that microbiota-derived metabolites significantly influence V. cholerae behavior. By investigating how an organic extract of human feces affects V. cholerae gene expression, we recently showed that gut metabolites strongly suppress swimming motility, a virulence factor important for host colonization. Interestingly, extracts of pure cultures of a single gut commensal, Enterocloster citroniae, recapitulated this inhibitory effect. Here, we present a comprehensive examination of the effect of small molecules produced by E. citroniae and related species on V. cholerae behavior. We show that E. citroniae small molecules inhibit motility by various V. cholerae strains. We also show that several phylogenetically related species produce this activity, although the magnitude of the effect varies between strains. Using biofilm formation assays in static and shear flow conditions, we show that V. cholerae strongly induces biofilm formation in response to E. citroniae metabolites. Transcriptome and reporter analyses show that several genes involved in the synthesis of an extracellular polysaccharide are induced by growth in the presence of E. citroniae metabolites. Lastly, we show that V. cholerae interactions with host epithelial cells are also modulated by compounds produced by this commensal. These findings advance our understanding of microbiome-pathogen interactions and how commensal bacteria influence V. cholerae virulence through the production of small molecules. In the future, this knowledge may be used to design novel microbiome-based therapeutic approaches to combat cholera and other infections.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313194" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE313132 ç‚ç—‡è¯±å¯¼çš„lncRNA SNHG1é€šè¿‡IL-17Aä¿¡å·é€šè·¯è°ƒæ§éæ¢—é˜»æ€§æ— ç²¾å­ç—‡ä¸­çš„ç²¾åŸç»†èƒå‘è‚²</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yongtong Zhu ; Maocai Li ; Xiaomin Zhan ; Li Liu ; Cairong Chen ; Yao Zhou ; Pei He ; Rui HuaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusNon-obstructive azoospermia (NOA) is a critical subtype of male infertility associated with inflammation. However, the molecular mechanisms underlying this phenomenon remain poorly understood. This study investigated the role of the inflammation-activated long non-coding RNA SNHG1 in NOA pathogenesis. Using lipopolysaccharide (LPS)-induced orchitis mouse models and spermatogonium cell lines (GC-1 spg and TCAM-2), we observed that both SNHG1 and the transcription factor SP1 were significantly upregulated, correlating with spermatogonium proliferation and loss of stemness. Mechanistically, SP1 directly binds to and transcriptionally activates the SNHG1 promoter, whereas SNHG1 knockdown rescued LPS-induced spermatogonium dysfunction without affecting SP1 expression. RNA-seq revealed that SNHG1 overexpression activated the IL-17A signaling pathway. Notably, IL-17A receptor blockade (Brodalumab) reversed the SNHG1-mediated proliferation arrest and stemness. Our findings demonstrated that the SP1-SNHG1-IL-17A axis drives inflammatory spermatogenic failure, suggesting that IL-17A inhibition is a potential therapeutic strategy for NOA.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313132" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE255449 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Siyao Guo ; Shuibin LinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe polyadenylation of mRNA is pivotal for mRNA stability and efficient mRNA translation. The length of poly(A) tail is dynamically changed under various physiological conditions; however, the functions and mechanisms of aberrant poly(A) length control in cancers remain poorly understood. Here we uncovered the aberrant lengthening of poly(A) tail and particularly upregulated expression of poly(A) polymerase alpha (PAPOLA) in acute myeloid leukemia (AML), and the elevated PAPOLA expression significantly correlated with unfavorable AML outcomes. We further demonstrated the critical oncogenic functions of PAPOLA-mediated poly(A) lengthening in promoting AML leukemogenesis and leukemia stem cell self-renewal using human primary AML samples, AML cells and various mouse leukemogenesis models. Mechanistically, we identified GSTM2 as a key downstream target of PAPOLA that regulated metabolic reprogramming through the HNE-DLD axis to promote AML initiation and progression. Moreover, PAPOLA inhibitor cordycepin effectively blocked metabolic reprogramming and AML leukemogenesis in vivo. Overall, our study uncovers the novel functional link between aberrant poly(A) lengthening and cellular metabolic reprogramming in AML, and provides a molecular basis for development of an effective therapeutic strategy for AML patients.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255449" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE294329 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºå¢ç”Ÿæ€§ç»ç’ƒä½“è§†ç½‘è†œç—…å˜è†œä¸­æˆçº¤ç»´ç»†èƒçš„å¼‚è´¨æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fengjuan Gao ; Yuqiao Ju ; Lili Zhang ; Ting Zhang ; Qing Chang ; Shunxiang Gao ; Xin Huang ; Yuan Zong ; Gezhi XuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensProliferative vitreoretinopathy (PVR) is a vision-threatening fibrotic disorder characterized by pathological membrane formation, yet its cellular and molecular mechanisms remain incompletely understood. Here, we employed single-cell RNA sequencing (scRNA-seq) to profile 18,213 cells from 5 human PVR membranes (PVRMs), uncovering cellular heterogeneity and novel pathogenic pathways.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294329" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE287936 DNAç”²åŸºåŒ–å’ŒlncRNAè¡¨è¾¾æ§åˆ¶å°è®°åŸºå› åŒºåŸŸçš„å¼‚æ­¥DNAå¤åˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmethylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yui Imaizumi ; Robert Feil ; Jean-Charles CadoretSeries Type : Genome variation profiling by genome tiling arrayOrganism : Mus musculusEukaryotic genomes are structured in zones that replicate predominantly early or late. Besides these genome-wide patterns of replication timing (RT), some genes display asynchronous replication between the two alleles in certain stem cells, brought about by stochastic processes and genetic polymorphisms. To what extent epigenetic modifications control asynchronous replication remains unclear. As a paradigm to address this question we explored imprinted chromosomal domains, at which parental DNA methylation imprints mediate parental allele-specific gene expression. Our genome-wide and locus-specific RT assays in mono-parental and hybrid mouse embryonic stem cells (mESCs) reveal a pronounced replication asynchrony between the parental chromosomes at the Dlk1-Dio3 and Snrpn domains. This asynchrony is strictly parent-of-origin dependent. By generating a range of mutant mESC lines, we find that the replication asynchrony at Dlk1-Dio3 is mediated by parental allele-specific methylation at DMRs (Differentially Methylated Regions). Moreover, lncRNA polycistron expression controls early replication across parts of the domain on the maternal chromosome. As a result, at these imprinted domains, RT domains become unlinked from 3D chromatin architecture as assayed by Hi-C. Our combined data highlight how parental DNA methylation imprints and lncRNA expression can locally be used to override intrinsic RT domain organization.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287936" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 11 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>7</td>
</tr>
<tr>
<td>leukemia</td>
<td>5</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>3</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>sequencing</td>
<td>1</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>1</td>
</tr>
<tr>
<td>methylation</td>
<td>1</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>1</td>
</tr>
<tr>
<td>carcinoma</td>
<td>1</td>
</tr>
<tr>
<td>immune</td>
<td>1</td>
</tr>
<tr>
<td>scRNA</td>
<td>1</td>
</tr>
<tr>
<td>gut</td>
<td>1</td>
</tr>
<tr>
<td>regex:gut(-?microbiome)?</td>
<td>1</td>
</tr>
<tr>
<td>inflammation</td>
<td>1</td>
</tr>
<tr>
<td>pathway</td>
<td>1</td>
</tr>
<tr>
<td>spatial</td>
<td>1</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (11æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254009" target="_blank" rel="noopener noreferrer">GSE254009 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [TT-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253121" target="_blank" rel="noopener noreferrer">GSE253121 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253120" target="_blank" rel="noopener noreferrer">GSE253120 NELF å¯é˜»æ­¢ç™Œç»†èƒ DNA å¤åˆ¶åŒºå‘ç”Ÿå¹¿æ³›çš„è½¬å½•å»¶ä¼¸ [POINT-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298740" target="_blank" rel="noopener noreferrer">GSE298740 ç”Ÿç‰©åˆ¶å‰‚æ²»ç–—çš„ T2 é«˜å±é‡ç—‡å“®å–˜æ‚£è€…çš„è½¬å½•ç»„å­¦ï¼šæŠ— IgEã€æŠ— IL-5 å’ŒæŠ— IL-5R é¶å‘æ²»ç–—çš„æ¯”è¾ƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294022" target="_blank" rel="noopener noreferrer">GSE294022 äººç±»å­å®«æµ†æ¶²æ€§ç™Œç»†èƒå’Œè‚¿ç˜¤å¯¹ CTX-439 çš„ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313231" target="_blank" rel="noopener noreferrer">GSE313231 RNA-seq æ•°æ®æ¥è‡ªæ¥å— S-100 è¯±å¯¼çš„è‡ªèº«å…ç–«æ€§è‚ç‚ (AIH) æ¨¡å‹å¤„ç†çš„ Alb-WT Bicd2fl/fl å’Œ Alb-Cre Bicd2fl/fl å°é¼ çš„è‚ç»„ç»‡ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308896" target="_blank" rel="noopener noreferrer">GSE308896 ç™Œç»†èƒé€šè¿‡èƒ¶åŸè›‹ç™½ä¸ä¸­åŒ…å«çš„microRNAè½¬ç§»ä¾µè¢­æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294315" target="_blank" rel="noopener noreferrer">GSE294315 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ï¼ˆå°é¼ ï¼‰ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255668" target="_blank" rel="noopener noreferrer">GSE255668 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255667" target="_blank" rel="noopener noreferrer">GSE255667 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[FLAM-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255603" target="_blank" rel="noopener noreferrer">GSE255603 PAPOLAä»‹å¯¼çš„poly(A)å»¶é•¿åœ¨ç™½è¡€ç—…ä¸­çš„åŠŸèƒ½å’Œæœºåˆ¶[RIP-Seq]</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-14 21:35</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>